Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.
about
Developing immunotherapeutic strategies to target brain tumors.Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.Engineering Chimeric Antigen Receptors.Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities.Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-Cell Malignancies.Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells.Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.NK-92 cell, another ideal carrier for chimeric antigen receptor.The development of CAR design for tumor CAR-T cell therapy.Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells.Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma.Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine GliomasCART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
P2860
Q38851464-5B5C5D5F-9E63-4026-B2AC-27BB0ACF97A8Q38987239-95F854BA-06EF-41E7-979D-0ACE91C1B92AQ39276909-5494857F-7333-4DF4-8578-53CC0A04502AQ45832774-88B81759-6CC0-4767-8E1C-C65708B32FDDQ45857417-970BF7DF-9079-4AC1-9391-A112BB059BE4Q45868285-AD68CD87-0B66-4206-83C0-A5623E7D1AADQ45873677-C7BD58C2-30D5-4548-A9D7-343C41936233Q47161416-E2A22024-3A0D-41F9-BDE3-4E38D329FC32Q47565868-2ED34E4F-8214-4BA4-B94A-FCBFAE3489AFQ50027824-85EAF8EB-55AB-44A9-B32D-FB44CE549658Q52641562-1B453BBC-9C9D-4F46-AD94-03A1FCE5C2DFQ52715479-C9EB487B-5B23-4B2E-8BCA-485BD45EC0E4Q55224144-01221920-3091-481E-8248-FD8F9DB6F50FQ55457493-05E5B047-AC90-453E-840B-93FBEA4FA033Q57300937-D515BC32-7488-4581-91C9-CA602F0E7426Q58606449-67C54AF6-1220-4A56-9958-93D283343AB9
P2860
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterization and Functiona ...... ls to IL13Rα2-positive Glioma.
@en
type
label
Characterization and Functiona ...... ls to IL13Rα2-positive Glioma.
@en
prefLabel
Characterization and Functiona ...... ls to IL13Rα2-positive Glioma.
@en
P2093
P2860
P356
P1433
P1476
Characterization and Functiona ...... lls to IL13Rα2-positive Glioma
@en
P2093
David Torres
Gianpietro Dotti
Irina V Balyasnikova
Maciej S Lesniak
Meng-Fen Wu
Simone Krebs
Stephen Gottschalk
Xiao-Nan Li
P2860
P304
P356
10.1038/MT.2015.199
P577
2015-10-30T00:00:00Z